Acknowledgments

The author would like to thank Ryan Smith for research assistance. Dr. Newton was supported in part by National Cancer Institute grant, CA 16058 and the Dardinger Neuro-Oncology Center Endowment Fund.

References

1. Newton, H. B. (1994). Primary brain tumors: Review of etiology, diagnosis, and treatment. Am Fam Physician 49, 787-797.

2. Preston-Martin, S. (1996). Epidemiology of primary CNS neoplasms. Neurol Clin 14, 273-290.

3. Davis, F. G., and McCarthy, B. J., (2001). Current epidemiological trends and surveillance issues in brain tumors. Expert Rev Anticancer Ther 1, 395-401.

4. Osborne, R. H., Houben, M. P. W. A., Tijssen, C. C., Coebergh, J. W. W., and van Duijn, C. M. (2001). The genetic epidemiology of glioma. Neurol 57, 1751-1755.

5. Wrensch, M., Minn, Y., Chew, T., Bondy, M., and Berger, M. S. (2002). Epidemiology of primary brain tumors: Current concepts and review of the literature. Neuro-Oncol 4, 278-299.

6. Hess, K. R., Broglio, D. R., and Bondy, M. L. (2004). Adult glioma incidence trends in the United States, 1977-2000. Cancer 101, 2293-2299.

7. Newton, H. B. (1999). Neurological complications of systemic cancer. Am Fam Phys 59, 878-886.

8. Legler, J. M., Ries, L. A., Smith, M. A. et al. (1999). Cancer surveillance series [corrected]: Brain and other central nervous system cancers: recent trends in incidence and mortality. J Natl Cancer Inst 91, 1382-1390.

9. ACS (American Cancer Society) (2002). Cancer Facts and Figures 2002. American Cancer Society, Atlanta.

10. Grovas, A., Fremgen, A., Rauck, A. et al. (1997). The National Cancer Data Base report on patterns of childhood cancers in the United States. Cancer 80, 2321-2332.

11. Bondy, M., Wiencke, J., Wrensch, M., and Kryitsis, A. P. (1994). Genetics of primary brain tumors: A review. J Neuro-Oncol 18, 69-81.

12. de Andrade, M., Barnholtz, J. S., Amos, C. I., Adatto, P., Spencer, C., and Bondy, M. L. (2001). Segregation analysis of cancer in families of glioma patients. Genet Epidemiol 20, 258-270.

13. Malmer, B., Gronberg, H., Bergenheim, A. T., and Lenner, P., and Henriksson, R. (1999). Familial aggregation of astrocytoma in northern Sweden: An epidemiological cohort study. In J Cancer 81, 366-370.

14. Elexpuru-Camiruaga, J., Buxton, N., Kandula, V. et al. (1995). Susceptibility to astrocytoma and meningioma: Influence of allelism at glutathione S-transferase (GSTT1 and GSTM1) and cytochrome P-450 (CYP2D6) loci Cancer Res 55, 4237-4239.

15. Trizna, Z., de Andrade, M., Kyritsis, A. P. et al. (1998). Genetic polymorphisms in glutathione S-transferase mu and theta, N-acetyltransferase, and CYP1A1 and risk of gliomas. Cancer Epidemiol Biomarkers Prev 7, 553-555.

16. Karlsson, P., Holmberg, E., Lundell, M., Mattsson, A., Holm, L. E., and Wallgren, A. (1998). Intracranial tumors after exposure to ionizing radiation during infancy: A pooled analysis of two Swedish cohorts of 28,008 infants with skin hemangioma. Radiat Res 150, 357-364.

17. Salvatai, M., Aratico, M., Caruso, R., Rocchi, G., Orlando, E. E. R., and Nucci, F. (1991). A report on radiation-induced gliomas. Cancer 67, 392-397.

18. Yeh, H., Matanoski, G. M., Wang, N., Sandler, D. P., and Comstock, G. W. (2001). Cancer incidence after childhood nasopharyngeal radium irradiation: A follow-up study in Washington County, Maryland. Am J Epidemiol 153, 749-756.

19. Shintani, T., Hayakawa, N., Hoshi, M. et al. (1999). High incidence of meningioma among Hiroshima atomic bomb survivors. J Radiat Res 40, 49-57.

20. Loomis, D. P., and Wolf, S. H. (1996). Mortality of workers at a nuclear materials production plant at Oak Ridge, Tennessee, 1947-1990. Am J Ind Med 29, 131-141.

21. Wong, O., Whorton, M. D., Follart, D. E., and Ragland, D. (1991). An industry-wide epidemiologic study of vinyl choride workers, 1942-1982. Am J Ind Med 20, 317-334.

22. McLaughlin, J. K., and Lipworth, L. (1999). A critical review of the epidemiologic literature on health effects of occupational exposure to vinyl chloride. J Epidemiol Biostat 4, 253-275.

23. Brenner, A. V., Linet, M. S., Fine, H. A. et al. (2002). History of allergies and autoimmune diseases and risk of brain tumors in adults. Int J Cancer 99, 252-256.

24. Kleihues, P., and Cavanee, W. K. (2000). Pathology and Genetics of Tumours of the Nervous System. International Agency for Research on Cancer, Lyon.

25. Kleihues, P., Louis, D. N., Scheithauer, B. W. et al. (2002). The WHO classification of tumors of the nervous system. J Neuropathol Exp Neurol 61, 215-225.

26. Okazaki, H. (Ed.) (1989). General methodology and pathologic cellular reactions. In Fundamentals of Neuropathology. Morphologic Basis of Neurologic Disorders, 2nd ed., pp. 1-26. Igaku-Shoin, New York.

27. Morrison, C. D., and Prayson, R. A. (2000). Immunohisto-chemistry in the diagnosis of neoplasms of the central nervous system. Sem Diagn Pathol 17, 204-215.

28. Raghavan, R., Steart, P., and Weller, R. O. (1990). Cell proliferation patterns in the diagnosis of astrocytomas, anaplastic astrocytomas, and glioblastoma multiforme: a Ki-67 study. Neuropathol Appl Neruobiol 16, 123-133.

29. Revesz, T., Alsanjari, N., Darling, J. L. et al. (1993). Proliferating cell nuclear antigen (PCNA): expression in samples of human astrocytic gliomas. Neuropathol. Appl Neurobiol 19, 152-158.

30. McLendon, R. E., Enterline, D. S., Tien, R. D., Thorstad, W. L., and Bruner, J. M. (1998). Tumors of central neuroepithelial origin. In Russell & Rubinstein's Pathology of Tumors of the Nervous System (D. D. Bigner, R. E. McLendon, and J. M. Bruner, Eds.), 6th ed., Vol.1, pp.307-571. Arnold, London.

31. Krouwer, H. G. J., Davis, R. L., Silver, R., and Prados, M. (1991). Gemistocytic astrocytomas: a reappraisal. J Neurosurg 74, 399-406.

32. Watanabe, K., Peraud, A., Gratas, C. et al. (1998). p53 and PTEN gene mutations in gemistocytic astrocytomas. Acta Neuropathol (Berl) 95, 559-564.

33. Peraud, A., Ansari, H., Bise, K., and Reulen, H. J. (1998). Clinical outcome of supratentorial astrocytoma WHO grade II. Acta Neurochir (Wien) 140, 1213-1222.

34. von Deimling, A., Louis, D. N., and Wiestler, O. D. (1995). Molecular pathways in the formation of gliomas. Glia 15, 128-138.

35. Louis, D. N., Holland, E. C., and Cairncross, J. G. (2001). Glioma classification. A molecular reappraisal. Am J Pathol 159, 779-786.

36. Maher, E. A., Furnari, F. B., Bachoo, R. M. et al. (2001). Malignant glioma: genetics and biology of a grave matter. Genes & Develop. 15, 1311-1333.

37. Ichimura, K., Ohgaki, H., Kleihues, P., and Collins, V. P. (2004). Molecular pathogenesis of astrocytic tumours. J Neuro-Oncol 70, 137-160.

38. Palma, L., Celli, P., Maleci, A. Di Lorenzo, N., and Cantore, G. (1989). Malignant monstrocellular brain tumours. A study of 42 surgically treated cases. Acta Neurochir (Wien) 97, 17-25.

39. Meis, J. M., Ho, K. L., and Nelson, J. S. (1990). Gliosarcoma: a histologic and immunohistochemical reaffirmation. Mod Pathol 3, 19-24.

40. Forsyth, P. A., Shaw, E. G., Scheithauer, B. W. et al. (1993). Supratentorial pilocytic astrocytomas: a clinicopathologic, prognostic, and flow cytometric study of 51 patients. Cancer 72, 1335-42.

41. Kepes, J. J. (1993). Pleomorphic xanthoastrocytoma: the birth of a diagnosis and a concept. Brain Pathol 3, 269-274.

42. Engelhard, H. H., Stelea, A., and Cochran, E. J. (2002). Oligodendrglioma: Pathology and molecular biology. Surg Neurol 58, 111-117.

43. Reifenberger, G., and Louis, D. N. (2003). Oligodendroglioma: Toward molecular definitions in diagnostic neuro-oncology. J Neuropathol Exp Neurol 62, 111-126.

44. Jeuken, J. W. M., von Deimling, A., and Wesseling, P. (2004). Molecular pathogenesis of oligodendroglial tumors. J Neuro-Oncol 70, 161-181.

45. Beckmann, J. M., and Prayson, R. A. (1997). A clinicopathologic study of 30 cases of oligoastrocytoma including p53 immuno-histochemistry. Pathol 29, 159-164.

46. Rosenblum, M. K. (1998). Ependymal tumors: A review of their diagnostic surgical pathology. Pediatr Neurosurg 28, 160-165.

47. Greene, K. A., Dickman, C. A., Marciano, F. F., Coons, S. W., and Rekate, H. L. (1994). Pathology and management of choroid plexus tumors. BNI Quarterly 10, 13-21.

48. Luyken, C., Bl├╝mcke, I., Fimmers, R., Urbach, H., Wiestler, O. D., and Schramm, J. (2004). Supratentorial ganglioglioams: Histopathologic grading and tumor recurrence in 184 patients with a median follow-up of 8 years. Cancer 101, 146-155.

49. Massoun, J., Soylemezoglu, F., Gambarelli, D., Figarella-Branger, D., von Ammon, K., and Kleihues, P. (1993). Central neurocytoma: A synopsis of clinical and histological features. Brain Pathol 3, 297-306.

50. Eberhart, C. G., and Burger, P. C. (2003). Anaplasia and grading in medulloblastomas. Brain Pathol 13, 376-385.

51. Rorke, L. B., Packer, R. J., and Biegel, J. A. (1996). Central nervous system atypical teratoid/rhabdoid tumors of infancy and childhood: definition of an entity. J Neurosurg 85, 56-65.

52. Lamszus, K. (2004). Meningioma pathology, genetics, and biology. J Neuropathol Exp Neurol 63, 275-286.

53. Perry, A., Gutmann, D. H., and Reifenberger, G. (2004). Molecular pathogenesis of meningiomas. J Neuro-Oncol 70, 183-202.

54. Jellinger, K. A., and Paulus, W. (1992). Primary central nervous system lymphomas - an update. J Cancer Res Clin Oncol 119, 7-27.

55. Matsutani, M., Sano, K., and Takakura, K., et al. (1997). Primary intracranial germ cell tumors: a clinical analysis of 153 histologically verified cases. J Neurosurg 86, 446-455.

PLATE 1.2 (Fig. 1.2) PLATE 1.3 (Fig. 1.3)
10 Ways To Fight Off Cancer

10 Ways To Fight Off Cancer

Learning About 10 Ways Fight Off Cancer Can Have Amazing Benefits For Your Life The Best Tips On How To Keep This Killer At Bay Discovering that you or a loved one has cancer can be utterly terrifying. All the same, once you comprehend the causes of cancer and learn how to reverse those causes, you or your loved one may have more than a fighting chance of beating out cancer.

Get My Free Ebook


Post a comment